Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Literature DB >> 9137077

Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

J T Isaacs¹.

Abstract

Entities: Disease

Mesh：

Substances：
Biomarkers, Tumor

Year: 1997 PMID： 9137077 PMCID： PMC1858207

Source DB: PubMed Journal: Am J Pathol ISSN： 0002-9440 Impact factor: 4.307

× No keyword cloud information.

86 in total

1. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.

Authors: J R Smith; D Freije; J D Carpten; H Grönberg; J Xu; S D Isaacs; M J Brownstein; G S Bova; H Guo; P Bujnovszky; D R Nusskern; J E Damber; A Bergh; M Emanuelsson; O P Kallioniemi; J Walker-Daniels; J E Bailey-Wilson; T H Beaty; D A Meyers; P C Walsh; F S Collins; J M Trent; W B Isaacs
Journal: Science Date: 1996-11-22 Impact factor: 47.728

2. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

Authors: S Gately; P Twardowski; M S Stack; M Patrick; L Boggio; D L Cundiff; H W Schnaper; L Madison; O Volpert; N Bouck; J Enghild; H C Kwaan; G A Soff
Journal: Cancer Res Date: 1996-11-01 Impact factor: 12.701

3. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.

Authors: J Hao; Y Yang; K M McDaniel; B L Dalkin; A E Cress; R B Nagle
Journal: Am J Pathol Date: 1996-10 Impact factor: 4.307

4. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.

Authors: J T Dong; H Suzuki; S S Pin; G S Bova; J A Schalken; W B Isaacs; J C Barrett; J T Isaacs
Journal: Cancer Res Date: 1996-10-01 Impact factor: 12.701

5. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.

Authors: J T Dong; P W Lamb; C W Rinker-Schaeffer; J Vukanovic; T Ichikawa; J T Isaacs; J C Barrett
Journal: Science Date: 1995-05-12 Impact factor: 47.728

6. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

Authors: J M Cunningham; A Shan; M J Wick; S K McDonnell; D J Schaid; D J Tester; J Qian; S Takahashi; R B Jenkins; D G Bostwick; S N Thibodeau
Journal: Cancer Res Date: 1996-10-01 Impact factor: 12.701

7. p53 is mutated in a subset of advanced-stage prostate cancers.

Authors: R Bookstein; D MacGrogan; S G Hilsenbeck; F Sharkey; D C Allred
Journal: Cancer Res Date: 1993-07-15 Impact factor: 12.701

8. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.

Authors: B V Kallakury; F Yang; J Figge; K E Smith; S J Kausik; N J Tacy; H A Fisher; R Kaufman; H Figge; J S Ross
Journal: Cancer Date: 1996-10-01 Impact factor: 6.860

9. p53 gene alterations in human prostate carcinoma.

Authors: P J Effert; R H McCoy; P J Walther; E T Liu
Journal: J Urol Date: 1993-07 Impact factor: 7.450

10. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.

Authors: M Salmi; K Grön-Virta; P Sointu; R Grenman; H Kalimo; S Jalkanen
Journal: J Cell Biol Date: 1993-07 Impact factor: 10.539

15 in total

1. Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.

Authors: S Karaburun Paker; B Kilicarslan; A M Ciftcioglu; S Oztekin; F C Sargin; T Erdogru; M Baykara
Journal: Pathol Oncol Res Date: 2001 Impact factor: 3.201

Review 2. Histopathology reporting of prostate needle biopsies. 2005 update.

Authors: Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal: Virchows Arch Date: 2006-04-22 Impact factor: 4.064

3. Survivin is a potential mediator of prostate cancer metastasis.

Authors: Min Zhang; John J Coen; Yoshiyuki Suzuki; Michael R Siedow; Andrzej Niemierko; Li-Yan Khor; Alan Pollack; Yifen Zhang; Anthony L Zietman; William U Shipley; Arnab Chakravarti
Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-16 Impact factor: 7.038

4. CSR1 suppresses tumor growth and metastasis of prostate cancer.

Authors: Guoying Yu; George C Tseng; Yan Ping Yu; Tim Gavel; Joel Nelson; Alan Wells; George Michalopoulos; Demetrius Kokkinakis; Jian-Hua Luo
Journal: Am J Pathol Date: 2006-02 Impact factor: 4.307

5. CSR1 induces cell death through inactivation of CPSF3.

Authors: Z-H Zhu; Y P Yu; Y-K Shi; J B Nelson; J-H Luo
Journal: Oncogene Date: 2008-09-22 Impact factor: 9.867

6. Role of immunohistochemistry and apoptosis as investigative tools in assessing the prognosis of patients with prostate tumours.

Authors: Srikumar Chakravarthi; P M Thani; David Low Wee Yang; Linda Tjoa Husin; Nagaraja Lee
Journal: Exp Ther Med Date: 2010-03-01 Impact factor: 2.447

10. Endorectal coil MRI and MR-spectroscopic imaging in patients with elevated serum prostate specific antigen with negative trus transrectal ultrasound guided biopsy.

Authors: Farooq Ahmad Ganie; Mohammad Saleem Wani; Feroz Shaheen; Mohd Lateef Wani; Shabir Ahmad Ganie; Mohd Farooq Mir; Shadab Nabi Wani
Journal: Urol Ann Date: 2013-07